Mediar Therapeutics
Health Care · Biotechnology

Mediar Therapeutics: Products & infrastructure

Mediar Therapeutics has 6 clinical trials on record, 3 under way.

Data updated Nov 20, 2026 · Back to the company report

Products

Mediar Therapeutics has 6 clinical trials on record, 3 under way.

6clinical trials
3trials under way
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
phase 1 · under way · 88 participants · Healthy Adult Participants; Diabetic Kidney Disease
May 2026
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
phase 2 · under way · 85 participants · Diffuse Cutaneous Systemic Sclerosis
Apr 2026
Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males
phase 1 · completed · 8 participants · Healthy Adult Male
Feb 2026
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
phase 2 · under way · 168 participants · Idiopathic Pulmonary Fibrosis
May 2025
A First-in-Human Safety Trial of MTX-474
phase 1 · completed · 78 participants · Healthy
Jul 2024
A First-in-Human Safety Trial of MTX-463
phase 1 · completed · 56 participants · Healthy
Apr 2024
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.